Roxadustat in CKD and transplant patients: A new era in anemia management

The aim of this study was to evaluate the efficacy and safety of Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the management of anemia in patients with chronic kidney disease (CKD), including hemodialysis-dependent (HDD), non-dialysis-dependent (NDD), and renal...

詳細記述

書誌詳細
出版年:Liaquat Medical Research Journal
主要な著者: Muhammad Tassaduq Khan, Sidrah Rashid, Syed Hasan farooq, Sabahat Sarfaraz, Rashid bin Hamid, Naranjan Lal
フォーマット: 論文
言語:英語
出版事項: Liaquat University of Medical and Health Sciences 2025-03-01
主題:
オンライン・アクセス:http://121.52.154.206/index.php/LMRJ/article/view/1284

類似資料